The aim of this study was to determine the role of the ATG16L1 (rs2241880) and IRGM (rs13361189 and rs4958847) genes polymorphism in Crohn's disease (CD) and ulcerative colitis (UC). Our study included 557 CD and 425 UC patients and 672 ethnically matched Spanish controls and a meta-analysis with the data published to date. The polymorphisms were genotyped using predesigned TaqMan single nucleotide polymorphism genotyping assays. There was a statistically significant difference in the distribution of the ATG16L1 rs2241880 G allele between CD patients and controls in the Spanish population: P ¼ 6.5 Â 10 À9 , odds ratio (OR) ¼ 1.62. Although no differences were observed between UC patients and controls in the Spanish cohort, a meta-analysis demonstrated that the ATG16L1 G allele increase significantly risk for UC (P ¼ 0.0003, pooled OR ¼ 1.08). In addition, our meta-analysis data showed that IRGM rs13361189 and rs4958847 polymorphisms were associated with CD (rs13361189 C allele P ¼ 1.07 Â 10
Introduction
Inflammatory bowel disease (IBD), which is usually classified into two clinical presentations, Crohn's disease (CD) and ulcerative colitis (UC), is a chronic relapsing and remitting disease of the intestinal tract. Although the aetiology of these diseases is not fully understood, there is strong support for a genetic component based on findings of familial aggregation, higher concordance in monozygotic twins and ethnic differences in disease prevalence. 1, 2 To date, different genetic studies have shown several genes playing a relevant role in these diseases, including NOD2/CARD15, 3 
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SLC22A4 and SLC22A5, 5, 6 TNFSF15, 7, 8 NOD1/CARD4 7 and IL23R.
9,10
NOD2/CARD15 is likely to be the major genetic factor contributing to CD. This gene encodes a protein directly involved in the innate immune response to microbial antigens. This fact and evidence derived from animal models and clinical studies [11] [12] [13] suggest that an inappropriate innate response to normal constituents of the luminal microflora plays a crucial role in the development of these diseases.
Recently, autophagy has been shown to be a key process in the innate immune response. Autophagy also contributes to endogenous major histocompatibility complex class II antigen presentation, reflecting its role in the adaptive response. Interestingly, recent genomewide association studies (GWASs) of CD have reported a strong association with two crucial genes in the autophagy process, ATG16L1 and IRGM. [14] [15] [16] [17] ATG16L1 encodes a protein that interacts with the Atg12p-Atg5p conjugate during formation of the preautophagosomal structure, which is essential for autophagy. [18] [19] [20] Association of CD with the ATG16L1 T300A (rs2241880) polymorphism was reported simultaneously by different GWASs. [14] [15] [16] A large number of subsequent association studies have replicated the strong association of this gene with CD. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] IRGM (immunity-related guanosine triphosphatase, the human homologue of mouse Irgm/Lrg47) encodes a GTP-binding protein that induces autophagy and plays an important role in innate immunity against intracellular pathogens. 35, 36 Association of two immediately flanking IRGM gene polymorphisms (rs13361189 and rs4958847) with CD has recently been reported. 17, 30, 37 Reduced activity of these genes would be expected to lead to persistence of intracellular bacteria, consistent with existing models of CD pathogenesis and the recent ATG16L1 and IRGM association reports.
The aim of this study was to determine the potential implication of IRGM and ATG16L1 polymorphisms to CD and UC in a Spanish population. In addition, our data were pooled with results from other available studies in a meta-analysis to determine the global role of these gene variants in IBD.
Results
Association study
Deviation from Hardy-Weinberg equilibrium was not observed in the entire cohorts for the ATG16L1 rs2241880 and IRGM rs13361189 and rs4958847 polymorphisms. Table 1 shows the ATG16L1 rs2241880 genotype and allele distribution in healthy controls and in CD, UC and IBD patients. The ATG16L1 rs2241880 G allele was strongly associated with susceptibility to CD in the Spanish population (63.0 vs 51.2%, P ¼ 6.5 Â 10 À09 , odds ratio (OR) ¼ 1.62 95% confidence interval (CI) 1.37-1.91). On the other hand, no statistically significant differences for the ATG16L1 rs2241880 were observed in genotype and allele frequencies between UC patients and controls. When we combined CD and UC patients, an increased frequency of the G allele was observed compared with controls (58.9 vs 51.2%, P ¼ 1.3 Â 10 À05 , OR ¼ 1.37, 95% CI 1.18-1.58), mainly due to the CD subgroup. No correlation was observed between this genetic variant and the following variables: disease localization, disease behaviour, disease severity, need for surgery and age of onset for both CD and UC patients (Supplementary Table 1 ).
The distribution of IRGM rs13361189 and rs4958847 genotypic and allelic frequencies in the Spanish population is shown in 
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Meta-analysis Figure 1 shows the meta-analysis of all studies with published allele frequencies for ATG16L1 rs2241880 in CD and UC, including this study. [14] [15] [16] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] 38, 39 Funnel plots and Egger tests were performed to analyse the publication bias of the meta-analysis. No statistically significant values were observed in CD studies (P ¼ 0.6) or UC studies (P ¼ 0.4), with symmetric funnel plots for both studies (Supplementary Figure 1) . These data indicate the absence of publication bias in our metaanalysis. Overall analysis of this variant in CD revealed statistically significant evidence for heterogeneity of the OR among the studies (I 2 ¼ 50%), and the random-effects model was chosen. The meta-analysis showed that the ATG16L1 rs2241880 susceptibility G allele is strongly associated with CD (pooled OR ¼ 1.33; combined P ¼ 8.2 Â 10 À67 ; Figure 1a ). With regard to UC, no heterogeneity was observed, and the fixed-effects model was chosen (I 2 ¼ 9.6%). The combined estimated OR was small but statistically significant (pooled OR ¼ 1.08; combined P ¼ 0.0003; Figure 1b) . Figure 2a shows the meta-analysis of IRGM rs13361189 in CD, which includes the original British cohorts, 17 German 30 and New Zealander 37 replication cohorts, and our Spanish population. We observed highly significant association of the susceptibility allele frequency (SAF) in the combined meta-analysis (pooled OR ¼ 1.34; combined P ¼ 1.07 Â 10 À19 ), confirming previous reports. With regard to the meta-analysis of the IRGM rs4958847 polymorphism, we also observed a highly significant association with CD (pooled OR ¼ 1.31; combined P ¼ 2.78 Â 10
À17
; Figure 2c ). For UC, we performed a meta-analysis with the published data 30, 37, 38 and our data. In agreement with our results, the metaanalysis of the IRGM polymorphisms detected an association with susceptibility to UC (rs13361189 pooled OR ¼ 1.16, combined P ¼ 0.0069; rs4958847 pooled OR ¼ 1.13, combined P ¼ 0.014; Figures 2b and d) .
There was no statistically significant evidence for heterogeneity of the OR among the studies for these IRGM rs13361189 and rs4958847 polymorphisms in CD or in CU, and the fixed-effects model was chosen (I 2 ¼ 0% for all studies). Publication bias in these studies was not found; the Egger test was not statistically significant, with symmetric funnel plots for all of the studies (Supplementary Figure 1) .
Gene-gene interaction
To test gene-gene interaction, CD patients and controls were stratified according to their NOD2/CARD15 phenotype. There were no differences in allele frequencies for the studied variants of IRGM and ATG16L1 between CARD15-positive (defined as carrying at least one NOD2/CARD15 variant) and CARD15-negative individuals (Supplementary Table 1) .
Discussion
This study offers several novel insights into the role of ATG16L1 in susceptibility to IBD. Data obtained for this first meta-analysis of ATG16L1 rs2241880 confirm that this variant is an important CD susceptibility genetic marker. Moreover, the meta-analysis suggests that this variant was prematurely excluded as a susceptibility marker for UC. The lack of association with UC in all the individual studies performed to date (only Prescott et al. 21 reported a modest significant association, P ¼ 0.03), including our case-control study, is probably due to the modest impact of this allele on disease susceptibility, reliably detectable only in well-powered large sample sizes. In this sense, the estimated power of our meta-analysis study comprising 9211 cases and 12 863 controls is 99.99% for an OR ¼ 1.3.
There was no evidence that the ATG16L1 rs2241880 polymorphism influences disease localisation, disease behaviour, disease severity, need for surgery and age of onset for both CD and UC patients (Supplementary Table 1) .
Although none of the other studies with similar IBD cohorts have found significant differences with specific CD or UC subphenotypes, Prescott et al. found that the ATG16L1 rs2241880 G allele was associated specifically with the ileal forms of CD. However, we cannot rule out the possibility that our study is underpowered to detect weak associations between ATG16L1 rs2241880 and IBD subphenotypes.
The dynamic balance between microbes, particularly commensal flora, and host defensive responses at the mucosal frontier has an important role in the initiation and pathogenesis of IBD. This fact is supported by the therapeutic benefits of antibiotic and probiotic treatment in IBD patients, 40, 41 the observation that specific enteric flora are found more commonly in patients than in controls, 42, 43 and studies in a variety of murine strains in which 'spontaneous' colitis seems to be entirely dependent on the presence of a luminal flora. [44] [45] [46] Autophagy has an important role in physiological and pathological processes, such as degradation of cytoplasmic components, cellular response to nutrient starvation and apoptosis. 47, 48 Moreover, autophagy is also relevant in innate 49, 50 and adaptive immunity. 51, 52 Atg16l in conjunction with an Atg12-Atg5 conjugate, has a crucial role in the elongation of isolation membranes and the initial step of autophagosome formation, 53 and it is essential in the targeting and destruction of pathogens 49 as well as in foreign (microbial) antigen processing and presentation 52 protecting against viruses, bacteria and other pathogens. The functional role of the ATG16L1 T300A amino-acid substitution (polar proline to nonpolar alanine) is not yet clear, but it lies at the highly evolutionary conserved position 300 in the N terminus of the WD-repeat domain in ATG16L1 and, therefore, may affect protein interactions with other components of the autophagosome. This effect could result in functionally altered phagosomes that would kill microbes less effectively, resulting in prolonged immune activation or incomplete pathogen clearance.
14 IRGM is a member of the p47 immunity-related GTPase family. It controls intracellular pathogens by autophagy in mice and humans. 54, 55 Parkes et al. 17 found two immediately flanking IRGM polymorphisms (rs13361189 and rs4958847) associated with CD in two different British cohorts. Further, they sequenced the whole gene and found no non-synonymous variants associated with CD, 17 suggesting that the causal variants may lie in the regulatory or exonic sequences of IRGM in linkage disequilibrium with the associated variants. Interestingly, in a very recent study McCarroll et al. 56 have shown that the causal variant responsible for IRGM Figure 1 Pooled data for the ATG16L1 rs2241880 susceptibility allele frequency (SAF). (a) Pooled data of Australian, 39 Belgian, 16 British, 14, 21, 23, 25 Canadian, 31 Dutch, 28 German, 14, 29, 30 Italian, 27, 33 Hungarian, 34 Japanese, 22 New Zealander, 26 North American 15, 24 and Spanish cohorts for Crohn's disease (CD). (b) Pooled data of Australian, 39 British, 21, 23, 37 Canadian, 31 Dutch, 28 German, 14, 29, 30 Italian, 33 Hungarian, 34 New Zealander, 26, 39 North American 15 and Spanish cohorts for ulcerative colitis (UC). The odds ratio (OR) estimate of each study is marked with a square. The size of the square represents the weight that the corresponding study exerts in the meta-analysis. The confidence intervals (CIs) of pooled estimates are displayed as a horizontal line. Breslow-Day test, Cochran Q-test, and inconsistency for heterogeneity for the overall analysis of data from all studies: (a) Breslow-Day:
Odds ratio meta-analysis plot [fixed effect] Figure 2 Pooled data for susceptibility allele frequency (SAF) of the IRGM rs13361189 and rs4958847polymorphisms. (a) rs13361189 pooled data of British, 17 German, 30 New Zealander 35 and Spanish cohorts for Crohn's disease (CD). (b) rs13361189 pooled data of British, 38 German, 30 New Zealander 37 and Spanish cohorts for ulcerative colitis (UC). (c) rs4958847 pooled data of British, 17 German, 30 New Zealander 37 and Spanish cohorts for CD. (d) Pooled data of British, 38 German, 30 New Zealander 37 and Spanish cohorts for UC. Pooled data of the metaanalysis were obtained with both fixed methods. The odds ratio (OR) estimate of each study is marked with a square. The size of the square represents the weight that the corresponding study exerts in the meta-analysis. The confidence intervals (CIs) of pooled estimates are displayed as a horizontal line. OR and 95% CI were estimated using a fixed-effects model. Breslow-Day test for heterogeneity for the overall analysis of data from all studies: (a) Breslow-Day:
association with CD is a 20-kb deletion polymorphism, immediately upstream of IRGM and in perfect linkage disequilibrium (r 2 ¼ 1.0) with the most significant CD-associated single nucleotide polymorphism (rs13361189). The deletion (CD risk) and reference (CD protective) haplotypes of IRGM showed distinct expression patterns that modulated cellular autophagy of internalised bacteria. These results suggest that the CD association of IRGM arises from an alteration in IRGM regulation that affects the efficacy of autophagy. We confirmed the association of both IRGM rs13361189 and rs4958847 polymorphisms with CD. Although these variants showed only a trend of association in our Spanish population, a combined meta-analysis showed a more significant association for both IRGM genetic variants than that obtained in previous studies.
Similarly, our meta-analysis data demonstrated that ATG16L1 and IRGM variants are associated with susceptibility to UC. The lack of association of IRGM with UC shown in individual studies performed to date, including our study, is probably due to the modest impact of this gene on disease susceptibility. However, we recognize that the association found was weak and that further studies are needed to clarify the role of IRGM in UC.
In conclusion, our findings confirm ATG16L1 rs2241880 and IRGM rs13361189 and rs4958847 polymorphisms as important markers for CD susceptibility and indicate that these ATG16L1 and IRGM genetic variants are also associated with UC.
Patients and methods
Study population Association study. We performed a case-control study, comprising 982 IBD patients (557 CD and 425 UC) and 672 healthy controls recruited from three hospitals in Spain: Hospital Virgen de las Nieves, Hospital Puerta del Mar and Hospital Central de Asturias. Both patients and controls were of Spanish white origin and were matched for age and sex. Patients were diagnosed according to standard clinical, endoscopic, radiologic and histopathologic criteria. 57 Information on demographics and clinical parameters of IBD patients has been published elsewhere. 58 All subjects gave written informed consent for the study. The study was approved by the local ethics committees of the corresponding hospitals.
Meta-analysis. We searched Medline for all publications relating to association studies with the ATG16l1 and IRGM genes, and we checked the references from the retrieved publications for additional studies. Familybased and paediatric IBD studies were excluded from the meta-analysis. We included 20 studies in the metaanalysis, 19 of which were conducted in Caucasian populations and 1 in Asian. The characteristics of the studies included in the meta-analysis are shown in Table 3 .
Genotyping methods
DNA from patients and controls was obtained from peripheral blood using standard methods. Samples were genotyped for ATG16L1 rs2241880 and IRGM rs13361189 and rs4958847 variants using a PCR system with a Meta-analysis. The meta-analysis was conducted using StatsDirect software (StatsDirect, Cheshire, UK). In all the studies, allele and genotyping frequencies were consistent with Hardy-Weinberg equilibrium for all the variants. In addition to the total group, we classified the studies by ethnic and country origin. For each study, the allele frequencies were derived from counting the genotypes in patients and controls. The effects of variants were assessed by comparing the allele frequencies between patients vs controls. For each meta-analysis, first the Breslow-Day and Cochran Q-tests for heterogeneity were performed. 60, 61 In addition, the I 2 -test was used to quantify any apparent inconsistency and was interpreted as the approximate proportion of total variation in study estimates that is due to heterogeneity rather than sampling error. 62 Pooled calculations of ORs were obtained using the fixed-effects model (MantelHaenszel) when heterogeneity was not observed (an I 2 value lower than 50%); otherwise a random-effects model (DerSimonian-Laird) was chosen. 63 Fixed-effects models assume that all studies aim to evaluate a common truth and that results differ by chance alone. They have the advantage of being relatively insensitive to small studies with exaggerated spurious effects but may be inappropriate if there is genuine heterogeneity in the size of genetic effects across subpopulations. Random-effects models anticipate that the studies may have genuine differences in their results; thus, they also incorporate a between-study variance in their estimates. Random-effects models are generally more conservative (that is, they provide wider confidence intervals when there is between-study heterogeneity). However, they may be influenced more by small studies with exaggerated spurious effects. 61 Publication bias was investigated by funnel plotting, in which the standard error of log(OR) of each study was plotted against its OR. An asymmetric plot suggested possible publication bias. Funnel plot asymmetry was assessed by the method of Egger's linear regression test, a linear regression approach to measure funnel plot asymmetry on the natural logarithm scale of the OR. 64 The significance of the intercept was determined by the t-test as suggested by Egger, and a P value of o0.05 was considered significant.
